Virtus LifeSci Biotech Clinical Trials ETF
10 hedge funds and large institutions have $1.5M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
MCP
1
Militia Capital Partners
Las Vegas,
Nevada
|
$834K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$217K |
3 |
3
LPL Financial
San Diego,
California
|
$241K |
4 |
4
Osaic Holdings
Scottsdale,
Arizona
|
$4.89K |
5 |
5
Morgan Stanley
New York
|
$163K |